𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis

✍ Scribed by Peter D. Kent; John M. Davis III; Mark D. P. Davis; Eric L. Matteson


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
466 KB
Volume
46
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Antinuclear antibodies following inflixi
✍ Leen De Rycke; Elli Kruithof; Nancy Van Damme; Ilse E. A. Hoffman; Nancy Van den πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## Abstract ## Objective To investigate the effect of infliximab treatment on antinuclear antibodies (ANAs), anti–double‐stranded DNA (anti‐dsDNA), antinucleosome, antihistone, and anti–extractable nuclear antigen (anti‐ENA) antibodies in rheumatoid arthritis (RA) and spondylarthropathy (SpA) pati

Local skin rash after intraarticular met
✍ YrjΓΆ T. Konttinen; Claes Friman; Erkki Tolvanen; Sakari Reitamo; Eija Johansson πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 2 views

Since corticosteroids have an antiinflammatory effect, it is highly improbable that they would cause allergic reactions (1). In one patient, an intraarticular injection of methyl prednisolone acetate caused a generalized maculopapular rash which appeared a few hours after injection and lasted 4 days

Improvement of renal function and disapp
✍ Maria Grazia Anelli; Diletta Domenica Torres; Carlo Manno; Crescenzio Scioscia; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 2 views

Reactive systemic AA amyloidosis is a severe complication of rheumatoid arthritis (RA), occurring in 2-5% of RA patients (1). Infliximab, a monoclonal antibody against tumor necrosis factor ␣ (TNF␣), is successfully used in the treatment of RA (2). TNF␣ plays a key role in inducing the synthesis of